ArticleCureus2026
Diffuse Gastrointestinal Polyposis Revealing Mantle Cell Lymphoma: A Case Highlighting a Diagnostic Pitfall.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mantle cell lymphoma (MCL) is an uncommon subtype of B-cell non-Hodgkin lymphoma characterized by heterogeneous clinical behavior and frequent extranodal involvement. Gastrointestinal (GI) manifestations are well recognized but often underdiagnosed, particularly when they present as multiple lymphomatous polyposis (MLP), which can closely resemble benign or hereditary polyposis syndromes. We report the case of a 47-year-old man presenting with chronic abdominal pain, diarrhea, pruritus, and unintentional weight loss. Endoscopic evaluation revealed diffuse sessile polypoid lesions throughout the GI tract, initially raising concern for familial adenomatous polyposis. Histopathological examination with immunophenotyping demonstrated MCL. Staging studies confirmed isolated GI involvement without distant organ infiltration. The patient was treated with rituximab-based combination immunochemotherapy, resulting in significant clinical improvement and partial endoscopic regression of lesions after two cycles. This case highlights GI-predominant MCL as a critical diagnostic consideration in adults presenting with diffuse polyposis. Histologic confirmation with immunohistochemistry is essential to avoid misdiagnosis and delays in systemic therapy. Early recognition of this rare presentation enables prompt treatment and improved outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.